tiprankstipranks
SynAct Pharma AB (SE:SYNACT)
:SYNACT
Sweden Market
SYNACT
SynAct Pharma AB
RESEARCH TOOLSreports
Want to see SE:SYNACT full AI Analyst Report?

SynAct Pharma AB (SYNACT) Income Statement

2 Followers

SynAct Pharma AB Income Statement

Last quarter (Q2 2025), SynAct Pharma AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q2, SynAct Pharma AB's net income was kr-27.52M. See SynAct Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit
kr 0.00kr -617.00Kkr -778.00Kkr -1.06Mkr -88.00K
Operating Expenses
kr 117.15Mkr 89.98Mkr 224.50Mkr 105.71Mkr 76.70M
Depreciation and Amortization
kr 0.00kr 74.58Mkr 778.00Kkr 1.06Mkr 88.00K
EBITDA
kr -117.15Mkr -15.40Mkr -222.70Mkr -105.71Mkr -76.62M
Operating Income
kr -117.15Mkr -89.98Mkr -224.50Mkr -105.70Mkr -76.70M
Other Income/Expenses
kr -1.84Mkr -845.00Kkr 220.00Kkr -1.36Mkr -110.00K
Pretax Income
kr -118.99Mkr -90.83Mkr -224.28Mkr -107.06Mkr -76.81M
Net Income
kr -110.83Mkr -82.40Mkr -215.81Mkr -99.20Mkr -69.30M
Per Share Metrics
Basic EPS
kr -2.17kr -2.08kr -6.64kr -3.60kr -2.67
Diluted EPS
kr -2.17kr -2.08kr -6.64kr -3.60kr -2.67
Weighted Average Shares Outstanding
 51.08M 39.53M 32.52M 27.59M 25.97M
Weighted Average Shares Outstanding (Diluted)
 51.08M 39.53M 32.52M 27.59M 25.97M
Currency in SEK

SynAct Pharma AB Earnings and Revenue History